🇺🇸 FDA
Patent

US 10526400

Humanized pertussis antibodies and used thereof

granted A61KA61K2039/507A61K39/40

Quick answer

US patent 10526400 (Humanized pertussis antibodies and used thereof) held by The Board of Regents of the University of Texas System expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K2039/507, A61K39/40, A61K45/06, A61P